184 related articles for article (PubMed ID: 19476113)
1. Serum levels of C-reactive protein and uric acid in patients with cardiac syndrome X.
Eroglu S; Elif Sade L; Yildirir A; Demir O; Bozbas H; Muderrisoglu H
Acta Cardiol; 2009 Apr; 64(2):207-11. PubMed ID: 19476113
[TBL] [Abstract][Full Text] [Related]
2. The serum pentraxin-3 is elevated in patients with cardiac syndrome X.
Büyükkaya E; Karakaş MF; Kurt M; Motor S; Akçay AB; Büyükkaya S; Karakaş E; Sen N
Turk Kardiyol Dern Ars; 2013 Jun; 41(4):290-5. PubMed ID: 23760115
[TBL] [Abstract][Full Text] [Related]
3. Uric acid level and its association with carotid intima-media thickness in patients with cardiac syndrome X.
Acikgoz N; Ermis N; Yagmur J; Muezzinoglu K; Karakus Y; Cansel M; Pekdemir H; Ozdemir R
Med Princ Pract; 2012; 21(2):115-9. PubMed ID: 22076385
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of C-reactive protein as a state marker in Cardiac Syndrome X.
Dollard J; Kearney P; Clarke G; Moloney G; Cryan JF; Dinan TG
Brain Behav Immun; 2015 Jan; 43():27-32. PubMed ID: 25064176
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum gamma-glutamyl transferase activity in patients with cardiac syndrome X and its relationship with carotid intima media thickness.
Yagmur J; Ermis N; Acikgoz N; Cansel M; Atas H; Karakus Y; Pekdemir H; Ozdemir R
Acta Cardiol; 2010 Oct; 65(5):515-9. PubMed ID: 21125972
[TBL] [Abstract][Full Text] [Related]
6. Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease.
Recio-Mayoral A; Rimoldi OE; Camici PG; Kaski JC
JACC Cardiovasc Imaging; 2013 Jun; 6(6):660-7. PubMed ID: 23643286
[TBL] [Abstract][Full Text] [Related]
7. Serum concentrations of galectin-3 in patients with cardiac syndrome X.
Bozcali E; Polat V; Aciksari G; Opan S; Bayrak IH; Paker N; Karakaya O
Atherosclerosis; 2014 Nov; 237(1):259-63. PubMed ID: 25282685
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the relationship between red cell distribution width and cardiac syndrome X.
Demirkol S; Balta S; Celik T; Arslan Z; Unlu M; Cakar M; Kucuk U; Demirbas S; Iyisoy A; Yokusoglu M
Kardiol Pol; 2013; 71(5):480-4. PubMed ID: 23788088
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of thiol levels, thiol/disulfide homeostasis and their relation with inflammation in cardiac syndrome X.
Altiparmak IH; Erkus ME; Sezen H; Demirbag R; Kaya Z; Sezen Y; Gunebakmaz O; Asoglu R; Besli F; Neselioglu S; Erel O
Coron Artery Dis; 2016 Jun; 27(4):295-301. PubMed ID: 26928883
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X.
Huang PH; Chen YH; Chen YL; Wu TC; Chen JW; Lin SJ
Heart; 2007 Sep; 93(9):1064-70. PubMed ID: 17488770
[TBL] [Abstract][Full Text] [Related]
11. Heart rate recovery after exercise and its relation with neutrophil-to-lymphocyte ratio in patients with cardiac syndrome X.
Yurtdaş M; Yaylali YT; Aladağ N; Özdemir M; Ceylan Y; Gençaslan M; Akbulut T
Coron Artery Dis; 2014 Sep; 25(6):485-92. PubMed ID: 24642808
[TBL] [Abstract][Full Text] [Related]
12. Obesity, inflammation and brachial artery flow-mediated dilatation: therapeutic targets in patients with microvascular angina (cardiac syndrome X).
Ong P; Sivanathan R; Borgulya G; Bizrah M; Iqbal Y; Andoh J; Gaze D; Kaski JC
Cardiovasc Drugs Ther; 2012 Jun; 26(3):239-44. PubMed ID: 22392186
[TBL] [Abstract][Full Text] [Related]
13. Elevated circulating soluble form of CD40 ligand in patients with cardiac syndrome X.
Dominguez-Rodriguez A; Abreu-Gonzalez P; Avanzas P; Gomez MA; Kaski JC
Atherosclerosis; 2010 Dec; 213(2):637-41. PubMed ID: 20980002
[TBL] [Abstract][Full Text] [Related]
14. Microvascular angina. The possible role of inflammation, uric acid, and endothelial dysfunction.
Sakr SA; Abbas TM; Amer MZ; Dawood EM; El-Shahat N; Abdel Aal IA; Ramadan MM
Int Heart J; 2009 Jul; 50(4):407-19. PubMed ID: 19609046
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study).
Brodov Y; Behar S; Goldenberg I; Boyko V; Chouraqui P
Am J Cardiol; 2009 Jul; 104(2):194-8. PubMed ID: 19576345
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of adiponectin and lipoprotein(a) levels in cardiac syndrome X.
Guler E; Guler GB; Kizilirmak F; Batgerel U; Demir GG; Gunes HM; Karaca O; Özcan Ö; Barutcu I; Turkmen MM; Esen AM
Herz; 2015 May; 40 Suppl 3():291-7. PubMed ID: 25676008
[TBL] [Abstract][Full Text] [Related]
17. Serum uric acid and slow coronary flow in cardiac syndrome X.
Elbasan Z; Sahin DY; Gür M; Seker T; Kıvrak A; Akyol S; Sümbül Z; Kuloğlu O; Caylı M
Herz; 2013 Aug; 38(5):544-8. PubMed ID: 23338958
[TBL] [Abstract][Full Text] [Related]
18. HDL-cholesterol is associated with systemic inflammation in cardiac syndrome X.
Tenekecioglu E; Yilmaz M; Demir S; Bekler A; Ozluk OA; Aydin U; Goncu T; Yontar OC
Minerva Med; 2015 Jun; 106(3):133-41. PubMed ID: 25028863
[TBL] [Abstract][Full Text] [Related]
19. Association of Uric Acid and C-reactive Protein with the Severity of Coronary Artery Disease Using SYNTAX Score and Clinical SYNTAX Score.
Xing Y; Guo JT; Gai LY; Liu B; Luo DL
Heart Surg Forum; 2019 Jun; 22(3):E247-E252. PubMed ID: 31237552
[TBL] [Abstract][Full Text] [Related]
20. Relation between cardiovascular risk factors and coronary microvascular dysfunction in cardiac syndrome X.
Sestito A; Lanza GA; Di Monaco A; Lamendola P; Careri G; Tarzia P; Pinnacchio G; Battipaglia I; Crea F
J Cardiovasc Med (Hagerstown); 2011 May; 12(5):322-7. PubMed ID: 21135582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
